A carregar...
New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to rise. Inhaled bronchodilators, such as long-acting muscarinic antagonists (LAMAs) and long-acting β(2)-agonists (LABAs), are central to the maintenance treatment of patients with COPD...
Na minha lista:
| Publicado no: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6135066/ https://ncbi.nlm.nih.gov/pubmed/30233171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S113306 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|